Danaher ($DHR) to buy Masimo ($MASI) for $180.00/share in cash under a Merger Agreement dated Feb 16,…
Filed with the SEC on · Summarized by InvestorsBot
Danaher ($DHR) to buy Masimo ($MASI) for $180.00/share in cash under a Merger Agreement dated Feb 16, 2026; announced Feb 17, 2026. Merger Sub will merge into Masimo, which will become a wholly owned Danaher subsidiary. 🤝🧾 #M&A #Healthcare
Transaction subject to HSR waiting period, required non‑U.S. antitrust & foreign direct investment approvals and Masimo stockholder approval. Masimo and Danaher will file proxy/SEC materials—investors urged to read filings when available. 📄⚖️ $DHR $MASI #SECFilings
Companies caution on risks: timing uncertainty, possibility deal may not close, regulatory or competing bids, termination-fee scenarios, employee/customer impacts and potential stock volatility if not consummated. ⚠️ $DHR $MASI #M&A #Risk